Barclays
BTMD icon

Barclays’s Biote Corp BTMD Stock Holding History

Barclays’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.8K Sell
39,038
-3,681
-9% -$7.58K ﹤0.01% 4181
2026
Q1 		$57.7K Sell
42,719
-40,223
-48% -$80.8K ﹤0.01% 4262
2025
Q4 		$216K Buy
82,942
+4,448
+6% +$12.2K ﹤0.01% 4270
2025
Q3 		$235K Sell
78,494
-8,572
-10% -$30.6K ﹤0.01% 4227
2025
Q2 		$350K Buy
87,066
+19,317
+29% +$71.3K ﹤0.01% 3960
2025
Q1 		$226K Sell
67,749
-9,629
-12% -$45.9K ﹤0.01% 3978
2024
Q4 		$478K Buy
77,378
+182
+0.2% +$1.06K ﹤0.01% 3845
2024
Q3 		$431K Buy
77,196
+26,510
+52% +$177K ﹤0.01% 3869
2024
Q2 		$379K Buy
50,686
+20,509
+68% +$127K ﹤0.01% 3216
2024
Q1 		$175K Sell
30,177
-9,328
-24% -$46.7K ﹤0.01% 4193
2023
Q4 		$195K Buy
39,505
+15,015
+61% +$77.4K ﹤0.01% 4430
2023
Q3 		$125K Buy
24,490
+21,669
+768% +$128K ﹤0.01% 3508
2023
Q2 		$19.1K Buy
+2,821
New +$16.7K ﹤0.01% 4143
2022
Q2 		– Sell
-649,870
Closed -$6.42M – 5034
2022
Q1 		$6.42M Buy
+649,870
New +$6.4M 0.01% 1106

Other funds holding BTMD

3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BP
Bandera Partners New York $284M AUM 33.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's BTMD Position: Q2 2026 in Review

Barclays reduced its Biote Corp (BTMD) stake by 8.6% in Q2 2026, selling an estimated $7.58K and leaving 39,038 shares worth $73.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4181.

Barclays first reported a position in BTMD in Q1 2022 and has held it in 14 quarters since. The position peaked at $6.42M in Q1 2022. 71 funds tracked by Wall St. Rank hold BTMD as of Q2 2026.

  • Barclays held 39,038 shares of Biote Corp worth $73.8K as of Q2 2026.
  • Barclays sold 3,681 Biote Corp shares in Q2 2026, an estimated $7.58K.
  • Biote Corp made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4181 holding.
  • Barclays first reported a position in Biote Corp in Q1 2022 and has held it in 14 quarters since.
  • Barclays's Biote Corp position peaked at $6.42M in Q1 2022.
  • 71 funds tracked by Wall St. Rank held Biote Corp as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.